USANA Health Sciences Inc
NYSE:USNA

Watchlist Manager
USANA Health Sciences Inc Logo
USANA Health Sciences Inc
NYSE:USNA
Watchlist
Price: 24.74 USD Market Closed
Market Cap: 467.6m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

USNA Price Targets Summary
USANA Health Sciences Inc

Wall Street analysts forecast USNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for USNA is 51.51 USD with a low forecast of 36.36 USD and a high forecast of 68.25 USD.

USNA Lowest Forecast
Wall Street Target
36.36 USD
47% Upside
USNA Average Forecast
Wall Street Target
51.51 USD
108% Upside
USNA Highest Forecast
Wall Street Target
68.25 USD
176% Upside
Lowest
Price Target
36.36 USD
47% Upside
Average
Price Target
51.51 USD
108% Upside
Highest
Price Target
68.25 USD
176% Upside
USANA Health Sciences Inc Competitors:
Price Targets
C
COLPAL
Colgate-Palmolive (India) Ltd
17% Upside
K
KAREX
Karex Bhd
43% Upside
B
BIO
Biome Australia Ltd
86% Upside
NATR
Natures Sunshine Products Inc
88% Upside
C
COLPAL
Colgate-Palmolive (India) Ltd
17% Upside
K
KAREX
Karex Bhd
43% Upside
B
BIO
Biome Australia Ltd
86% Upside
NATR
Natures Sunshine Products Inc
88% Upside
4527
Rohto Pharmaceutical Co Ltd
41% Upside
A
4936
Axxzia Inc
158% Upside
BRBR
Bellring Brands Inc
16% Upside
W7L
Warpaint London PLC
97% Upside

Revenue
Forecast

Revenue Estimate
USANA Health Sciences Inc

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's revenue is -2%. The projected CAGR for the next 2 years is 11%.

-2%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
USANA Health Sciences Inc

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's operating income is -9%. The projected CAGR for the next 2 years is 7%.

-9%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
USANA Health Sciences Inc

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's net income is -10%. The projected CAGR for the next 2 years is 19%.

-10%
Past Growth
19%
Estimated Growth
Estimates Accuracy
20%
Average Beat
What are analyst estimates?

See Also

Summary
USNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
USNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
USNA stock valuation using valuation multiples.
Wall Street Estimates
USNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
USNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is USNA's stock price target?
Price Target
51.51 USD

According to Wall Street analysts, the average 1-year price target for USNA is 51.51 USD with a low forecast of 36.36 USD and a high forecast of 68.25 USD.

What is USANA Health Sciences Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's revenue is -2%. The projected CAGR for the next 2 years is 11%.

What is USANA Health Sciences Inc's Operating Income forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's operating income is -9%. The projected CAGR for the next 2 years is 7%.

What is USANA Health Sciences Inc's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for USANA Health Sciences Inc's net income is -10%. The projected CAGR for the next 2 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 246,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.